Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.6.6, indicating a newer software revision has been applied.SummaryDifference0.1%

- Check26 days agoChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added under the Other Study ID Numbers, indicating NIH grant support for the study.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor site update without altering the clinical trial information presented.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.6.3 has been added, replacing v3.6.2, representing a minor backend/page update without affecting study content.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page's revision label changes from v3.6.0 to v3.6.2, signaling a newer edition of the page's metadata.SummaryDifference0.1%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.